1 We investigated the effects of the non-peptide NK1 receptor antagonist, CP-96,345, its inactive enantiomer CP-96,344, and the racemic mixture ( ± )-CP-96,345, on the binding of [3H]-nimodipine and [3H]-diltiazem to L-type calcium channels in rat cerebral cortex membranes. In isolated peripheral tissues containing tachykinin receptors, the effects of (± )-CP-96,345 have been compared with those of diltiazem.2 In guinea-pig trachea, (± )-CP-96,345 produced antagonism of responses to the selective NK, agonists [Sar9, Met(02)"]SP and substance P-methyl ester that was apparently competitive in nature (pKB 7.0-7.5), while in guinea-pig ileum the antagonism was not surmountable. 3 The reduction of maximum responses by ( ± )-CP-96,345 in the guinea-pig ileum was not selective; it was obtained with muscarinic agonists and other agents, and was also observed in the portal vein of the rat where NK, receptors are not present. The functional effect that may be observed in integrated models will be a consequence of either property, or be a composite effect of NK, receptor antagonism and L-channel blockade.